New hope for kids with tough cancers: modified transplant trial opens
NCT ID NCT05011422
Summary
This early-stage study is testing the safety and effectiveness of a new type of stem cell transplant for children with high-risk or returning blood cancers like leukemia. The procedure uses a partially matched family donor's cells that are specially processed to remove certain immune cells, aiming to reduce complications while fighting the cancer. Researchers will closely monitor 50 children to see how well they recover and if the cancer stays away.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.